DK0815095T3 - 10-deacetylbaccatin III- og 10-deacetyl-14beta-hydroxybaccatin III-derivater, fremgangsmåde til fremstilling deraf og farma - Google Patents
10-deacetylbaccatin III- og 10-deacetyl-14beta-hydroxybaccatin III-derivater, fremgangsmåde til fremstilling deraf og farmaInfo
- Publication number
- DK0815095T3 DK0815095T3 DK96904100T DK96904100T DK0815095T3 DK 0815095 T3 DK0815095 T3 DK 0815095T3 DK 96904100 T DK96904100 T DK 96904100T DK 96904100 T DK96904100 T DK 96904100T DK 0815095 T3 DK0815095 T3 DK 0815095T3
- Authority
- DK
- Denmark
- Prior art keywords
- iii
- deacetyl
- 14beta
- pharmaceuticals
- preparation
- Prior art date
Links
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 title abstract 3
- FNZPZCTVRVPPAB-YZSQHPIKSA-N (2ar,4s,4as,6r,9r,10s,11r,12s,12ar,12bs)-12b-(acetyloxy)-12-(benzoyloxy)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-dodecahydro-4,6,9,10,11-pentahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5h-cyclodeca[3,4]benz[1,2-b]oxet-5-one Chemical class O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)[C@H](O)[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 FNZPZCTVRVPPAB-YZSQHPIKSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical group NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 abstract 1
- 229940123237 Taxane Drugs 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95MI000533A IT1275936B1 (it) | 1995-03-17 | 1995-03-17 | Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni |
| PCT/EP1996/000904 WO1996029321A1 (en) | 1995-03-17 | 1996-03-04 | 10-DEACETYLBACCATINE III AND 10-DEACETYL 14β-HYDROXYBACCATINE III DERIVATIVES, A PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0815095T3 true DK0815095T3 (da) | 2000-08-07 |
Family
ID=11370949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96904100T DK0815095T3 (da) | 1995-03-17 | 1996-03-04 | 10-deacetylbaccatin III- og 10-deacetyl-14beta-hydroxybaccatin III-derivater, fremgangsmåde til fremstilling deraf og farma |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US5750562A (it) |
| EP (1) | EP0815095B1 (it) |
| JP (4) | JP4101289B2 (it) |
| KR (2) | KR100388877B1 (it) |
| CN (2) | CN1176914C (it) |
| AT (1) | ATE193286T1 (it) |
| AU (1) | AU705923B2 (it) |
| CA (1) | CA2215682C (it) |
| DE (1) | DE69608548T2 (it) |
| DK (1) | DK0815095T3 (it) |
| ES (1) | ES2146389T3 (it) |
| GR (1) | GR3033742T3 (it) |
| HK (1) | HK1005242A1 (it) |
| IT (1) | IT1275936B1 (it) |
| NO (1) | NO317056B1 (it) |
| PT (1) | PT815095E (it) |
| RU (1) | RU2152936C1 (it) |
| WO (1) | WO1996029321A1 (it) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283633B1 (it) * | 1996-05-10 | 1998-04-23 | Indena Spa | Derivati tassanici loro sintesi e formulazioni che li contengono |
| ITMI991483A1 (it) * | 1999-07-06 | 2001-01-06 | Indena Spa | Derivati tassanici e procedimenti per la loro preparazione |
| EP2289549A3 (en) | 1999-10-01 | 2011-06-15 | Immunogen, Inc. | Immunoconjugates for treating cancer |
| IT1318678B1 (it) * | 2000-08-10 | 2003-08-27 | Indena Spa | Procedimento per la preparazione di derivati della baccatina iii. |
| ITMI20012186A1 (it) * | 2001-10-19 | 2003-04-19 | Indena Spa | Procedimento per la preparazione della 14-beta-idrossi-baccatina iii-1,14-carbonato |
| ITMI20012185A1 (it) * | 2001-10-19 | 2003-04-19 | Indena Spa | Procedimento per la preparazione della 14beta-idrossi-baccatina iii-1,14-carbonato |
| ITMI20021921A1 (it) * | 2002-09-10 | 2004-03-11 | Indena Spa | Funzionalizzazione della posizione 14 dei nuclei tassanici e sintesi di nuovi derivati antitumorali. |
| ATE377593T1 (de) | 2003-09-25 | 2007-11-15 | Tapestry Pharmaceuticals Inc | 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung |
| RU2008142363A (ru) * | 2006-03-27 | 2010-05-10 | Тэпистри Фармасьютикалз, Инк. (Us) | Конвергентный способ синтеза таксановых производных |
| EP2029563A4 (en) * | 2006-06-12 | 2009-12-02 | Canada Inc 6570763 | SEMI-SYNTHETIC PATHWAY FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATINE III FROM 9-DIHYDRO-13-ACETYLBACCATINE III |
| US7847111B2 (en) | 2006-06-19 | 2010-12-07 | Canada Inc. | Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| WO2008106621A1 (en) | 2007-02-28 | 2008-09-04 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| WO2008121476A1 (en) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| ES2389518T3 (es) | 2008-01-18 | 2012-10-26 | Indena S.P.A. | Formas sólidas de ortataxel |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380916A (en) * | 1990-11-02 | 1995-01-10 | University Of Florida | Method for the isolation and purification of taxane derivatives |
| IT1254517B (it) * | 1992-03-06 | 1995-09-25 | Indena Spa | 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico |
| US5200534A (en) * | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| ATE136460T1 (de) * | 1992-07-01 | 1996-04-15 | Bristol Myers Squibb Co | Fluor-taxole mit antitumor-wirkung |
| US5319112A (en) * | 1992-08-18 | 1994-06-07 | Virgnia Tech Intellectual Properties, Inc. | Method for the conversion of cephalomannine to taxol and for the preparation of N-acyl analogs of taxol |
| MX9307777A (es) * | 1992-12-15 | 1994-07-29 | Upjohn Co | 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. |
| NO310238B1 (no) * | 1992-12-24 | 2001-06-11 | Bristol Myers Squibb Co | Kjemiske forbindelser og farmasöytisk preparat samt anvendelse av slike preparater |
| US5475011A (en) * | 1993-03-26 | 1995-12-12 | The Research Foundation Of State University Of New York | Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment |
| IT1261667B (it) * | 1993-05-20 | 1996-05-29 | Tassano ad attivita' antitumorale. | |
| ATE249448T1 (de) * | 1993-06-11 | 2003-09-15 | Upjohn Co | Delta 6,7-taxol derivate antineoplastische verbindungen und diese enthaltende pharmazeutische zusammenstellungen |
| IL109926A (en) * | 1993-06-15 | 2000-02-29 | Bristol Myers Squibb Co | Methods for the preparation of taxanes and microorganisms and enzymes utilized therein |
| FR2707293A1 (fr) * | 1993-07-08 | 1995-01-13 | Rhone Poulenc Rorer Sa | Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent. |
-
1995
- 1995-03-17 IT IT95MI000533A patent/IT1275936B1/it active IP Right Grant
- 1995-06-06 US US08/471,137 patent/US5750562A/en not_active Expired - Lifetime
-
1996
- 1996-03-04 AT AT96904100T patent/ATE193286T1/de active
- 1996-03-04 DK DK96904100T patent/DK0815095T3/da active
- 1996-03-04 CN CNB01137067XA patent/CN1176914C/zh not_active Expired - Lifetime
- 1996-03-04 US US08/913,861 patent/US5973163A/en not_active Expired - Lifetime
- 1996-03-04 EP EP96904100A patent/EP0815095B1/en not_active Expired - Lifetime
- 1996-03-04 RU RU97117166/04A patent/RU2152936C1/ru active
- 1996-03-04 PT PT96904100T patent/PT815095E/pt unknown
- 1996-03-04 JP JP52801996A patent/JP4101289B2/ja not_active Expired - Lifetime
- 1996-03-04 KR KR10-2002-7014226A patent/KR100388877B1/ko not_active IP Right Cessation
- 1996-03-04 WO PCT/EP1996/000904 patent/WO1996029321A1/en active IP Right Grant
- 1996-03-04 ES ES96904100T patent/ES2146389T3/es not_active Expired - Lifetime
- 1996-03-04 CN CNB961926074A patent/CN100335470C/zh not_active Expired - Lifetime
- 1996-03-04 AU AU48320/96A patent/AU705923B2/en not_active Expired
- 1996-03-04 KR KR1019970706439A patent/KR100388878B1/ko not_active IP Right Cessation
- 1996-03-04 DE DE69608548T patent/DE69608548T2/de not_active Expired - Lifetime
- 1996-03-04 CA CA002215682A patent/CA2215682C/en not_active Expired - Lifetime
-
1997
- 1997-09-16 NO NO19974266A patent/NO317056B1/no not_active IP Right Cessation
-
1998
- 1998-05-12 HK HK98104095A patent/HK1005242A1/xx not_active IP Right Cessation
-
2000
- 2000-06-22 GR GR20000401437T patent/GR3033742T3/el unknown
-
2007
- 2007-02-28 JP JP2007049738A patent/JP2007137898A/ja not_active Withdrawn
-
2010
- 2010-12-06 JP JP2010271599A patent/JP2011046744A/ja active Pending
-
2012
- 2012-04-13 JP JP2012091985A patent/JP2012140465A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0815095T3 (da) | 10-deacetylbaccatin III- og 10-deacetyl-14beta-hydroxybaccatin III-derivater, fremgangsmåde til fremstilling deraf og farma | |
| DE69507702T2 (de) | Semisynthetisch taxal derivate mit antitumor wirkung | |
| DE69223624D1 (de) | Taxan-derivate enthaltende arzneimittel | |
| NL980012I2 (nl) | Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. | |
| TW352384B (en) | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals | |
| SI0801649T1 (en) | Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof | |
| DE69231663T2 (de) | Polysaccharid-protein-konjugate | |
| FI955424A0 (fi) | Syklodekstriinien kanssa muodostettuja taksoli- ja taksoteeri- tai Taxus-uuteinkluusiokomplekseja ja niiden valmistus ja käyttö | |
| GR3034575T3 (en) | Steroid nitrite ester derivatives useful as anti-inflammatory drugs | |
| HUP9701660A2 (hu) | 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények | |
| DE3770726D1 (de) | Decahydrochinolinderivate, verfahren zu ihrer herstellung und zwischenprodukte davon, ihre verwendung als arzneimittel und ihre pharmazeutischen zusammensetzungen. | |
| DE69627184D1 (de) | 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften | |
| IT1278108B1 (it) | Secotassani dotati di attivita' antitumorale. | |
| DE3880348D1 (de) | N-substituierte alpha-mercaptomethylbenzenpropanamid-derivate, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen. | |
| UA18224A (uk) | Спосіб лікуваhhя дерматозів | |
| IT1274356B (it) | Tassani semisintetici odtati di attivita' antitumorale |